Telehealth and In-Person Lung Cancer Screening Consultations Show Equivalent Quality

Lung cancer remains a leading cause of mortality in the United States, although recent data show that improvements in early detection and treatment have significantly accelerated declines in death rates [1, 2]. To maximize these gains, clinical guidelines emphasize the necessity of shared decision-making, a process that ensures screening choices align with individual patient values and goals [3, 4]. While low-dose computed tomography is effective at reducing mortality, real-world implementation often struggles with low participation rates and barriers to access [5, 6]. Interventions such as patient navigation and decision aids have been shown to improve screening uptake, yet the impact of the delivery medium itself remains a critical question for busy practices [7, 6]. A new study now evaluates how the shift toward telehealth affects the quality of these essential clinical conversations.